Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer
Clinical trial NCT01145404 · TERMINATED
Trial details
- NCT number
- NCT01145404
- Sponsor
- National Center for Tumor Diseases, Heidelberg
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-02-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.